British Patient Capital Announces €30m Commitment to Partech Growth II

  • Banking
  • 30.11.2021 09:45 am

British Patient Capital has made a €30m commitment to Partech Growth II, which announced its final close today at €650m.

Partech is one of the most active tech-specialist venture capital firms in the world, and this latest fund is one of the largest growth funds in Europe. It aims to back between 12 and 15 digital scale-ups, investing between €20m and €70m in each business across sectors such as enterprise software, consumer, healthcare, financial services, education and other frontier technologies. 

Judith Hartley, CEO, British Patient Capital, said: “We are delighted to be partnering with Partech on their latest fund. They have a strong track record in backing innovative tech companies, which includes home-grown success stories such as Made.com and Brandwatch. This €30m commitment aligns with our strategy to support later stage UK businesses, and we look forward to working with Partech to produce the next generation of digital leaders.”

Omri Benayoun, General Partner, Partech Growth, said: “We’re humbled and grateful for the support of, and commitment from, our global investors. It allows us to continue to deliver meaningful and strategic assistance to the outstanding community of European tech entrepreneurs who decide to welcome us on their journey.”

Related News